1 Study Coverage |
|
1.1 Immunotherapy Product Introduction |
|
1.2 Market by Type |
|
| 1.2.1 Global Immunotherapy Market Size Growth Rate by Type | |
| 1.2.2 Monoclonal Antibodies | |
| 1.2.3 Therapeutic Vaccines | |
| 1.2.4 Checkpoint Inhibitors | |
| 1.2.5 Non-Specific Immunotherapy | |
1.3 Market by Application |
|
| 1.3.1 Global Immunotherapy Market Size Growth Rate by Application | |
| 1.3.2 Oncology | |
| 1.3.3 Inflammation | |
| 1.3.4 Central Nervous System | |
| 1.3.5 Others | |
1.4 Study Objectives |
|
1.5 Years Considered |
|
2 Executive Summary |
|
2.1 Global Immunotherapy Market Size, Estimates and Forecasts |
|
| 2.1.1 Global Immunotherapy Revenue 2016-2027 | |
| 2.1.2 Global Immunotherapy Sales 2016-2027 | |
2.2 Global Immunotherapy, Market Size by Region: 2016 VS 2021 VS 2027 |
|
2.3 Immunotherapy Historical Market Size by Region (2016-2021) |
|
| 2.3.1 Global Immunotherapy Retrospective Market Scenario in Sales by Region: 2016-2021 | |
| 2.3.2 Global Immunotherapy Retrospective Market Scenario in Revenue by Region: 2016-2021 | |
2.4 Immunotherapy Market Estimates and Projections by Region (2022-2027) |
|
| 2.4.1 Global Immunotherapy Sales Forecast by Region (2022-2027) | |
| 2.4.2 Global Immunotherapy Revenue Forecast by Region (2022-2027) | |
3 Global Immunotherapy Competitor Landscape by Players |
|
3.1 Global Top Immunotherapy Manufacturers by Sales |
|
| 3.1.1 Global Immunotherapy Sales by Manufacturer (2016-2021) | |
| 3.1.2 Global Immunotherapy Sales Market Share by Manufacturer (2016-2021) | |
3.2 Global Top Immunotherapy Manufacturers by Revenue |
|
| 3.2.1 Key Immunotherapy Manufacturers Covered: Ranking by Revenue | |
| 3.2.2 Global Immunotherapy Revenue by Manufacturers (2016-2021) | |
| 3.2.3 Global Immunotherapy Revenue Share by Manufacturers (2016-2021) | |
| 3.2.4 Global Immunotherapy Market Concentration Ratio (CR5 and HHI) (2016-2021) | |
| 3.2.5 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2020 | |
| 3.2.6 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) | |
3.3 Global Immunotherapy Price by Manufacturers |
|
3.4 Global Immunotherapy Manufacturing Base Distribution, Product Types |
|
| 3.4.1 Immunotherapy Manufacturers Manufacturing Base Distribution, Headquarters | |
| 3.4.2 Manufacturers Immunotherapy Product Type | |
| 3.4.3 Date of International Manufacturers Enter into Immunotherapy Market | |
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans |
|
4 Breakdown Data by Type (2016-2027) |
|
4.1 Global Immunotherapy Market Size by Type (2016-2021) |
|
| 4.1.1 Global Immunotherapy Sales by Type (2016-2021) | |
| 4.1.2 Global Immunotherapy Revenue by Type (2016-2021) | |
| 詳情：http://www.5269660.cn/0/95/2021-2027-Global-and-China-Immunotherapy-Market-In-Depth-Research-and-Trends-Forecast-Re.html | |
| 4.1.3 Immunotherapy Average Selling Price (ASP) by Type (2016-2021) | |
4.2 Global Immunotherapy Market Size Forecast by Type (2022-2027) |
|
| 4.2.1 Global Immunotherapy Sales Forecast by Type (2022-2027) | |
| 4.2.2 Global Immunotherapy Revenue Forecast by Type (2022-2027) | |
| 4.2.3 Immunotherapy Average Selling Price (ASP) Forecast by Type (2022-2027) | |
5 Breakdown Data by Application (2016-2027) |
|
5.1 Global Immunotherapy Market Size by Application (2016-2021) |
|
| 5.1.1 Global Immunotherapy Sales by Application (2016-2021) | |
| 5.1.2 Global Immunotherapy Revenue by Application (2016-2021) | |
| 5.1.3 Immunotherapy Price by Application (2016-2021) | |
5.2 Immunotherapy Market Size Forecast by Application (2022-2027) |
|
| 5.2.1 Global Immunotherapy Sales Forecast by Application (2022-2027) | |
| 5.2.2 Global Immunotherapy Revenue Forecast by Application (2022-2027) | |
| 5.2.3 Global Immunotherapy Price Forecast by Application (2022-2027) | |
6 China by Players, Type and Application |
|
6.1 China Immunotherapy Market Size YoY Growth 2016-2027 |
|
| 6.1.1 China Immunotherapy Sales YoY Growth 2016-2027 | |
| 6.1.2 China Immunotherapy Revenue YoY Growth 2016-2027 | |
| 6.1.3 China Immunotherapy Market Share in Global Market 2016-2027 | |
6.2 China Immunotherapy Market Size by Players (International and Local Players) |
|
| 6.2.1 China Top Immunotherapy Players by Sales (2016-2021) | |
| 6.2.2 China Top Immunotherapy Players by Revenue (2016-2021) | |
6.3 China Immunotherapy Historic Market Review by Type (2016-2021) |
|
| 6.3.1 China Immunotherapy Sales Market Share by Type (2016-2021) | |
| 6.3.2 China Immunotherapy Revenue Market Share by Type (2016-2021) | |
| 6.3.3 China Immunotherapy Price by Type (2016-2021) | |
6.4 China Immunotherapy Market Estimates and Forecasts by Type (2022-2027) |
|
| 6.4.1 China Immunotherapy Sales Forecast by Type (2022-2027) | |
| 6.4.2 China Immunotherapy Revenue Forecast by Type (2022-2027) | |
| 6.4.3 China Immunotherapy Price Forecast by Type (2022-2027) | |
6.5 China Immunotherapy Historic Market Review by Application (2016-2021) |
|
| 6.5.1 China Immunotherapy Sales Market Share by Application (2016-2021) | |
| 6.5.2 China Immunotherapy Revenue Market Share by Application (2016-2021) | |
| 6.5.3 China Immunotherapy Price by Application (2016-2021) | |
6.6 China Immunotherapy Market Estimates and Forecasts by Application (2022-2027) |
|
| 6.6.1 China Immunotherapy Sales Forecast by Application (2022-2027) | |
| 6.6.2 China Immunotherapy Revenue Forecast by Application (2022-2027) | |
| 6.6.3 China Immunotherapy Price Forecast by Application (2022-2027) | |
7 North America |
|
7.1 North America Immunotherapy Market Size YoY Growth 2016-2027 |
|
7.2 North America Immunotherapy Market Facts & Figures by Country |
|
| 7.2.1 North America Immunotherapy Sales by Country (2016-2021) | |
| 7.2.2 North America Immunotherapy Revenue by Country (2016-2021) | |
| 7.2.3 U.S. | |
| 7.2.4 Canada | |
8 Asia Pacific |
|
8.1 Asia Pacific Immunotherapy Market Size YoY Growth 2016-2027 |
|
8.2 Asia Pacific Immunotherapy Market Facts & Figures by Region |
|
| 8.2.1 Asia Pacific Immunotherapy Sales by Region (2016-2021) | |
| 8.2.2 Asia Pacific Immunotherapy Revenue by Region (2016-2021) | |
| 8.2.3 China | |
| 8.2.4 Japan | |
| 8.2.5 South Korea | |
| 8.2.6 India | |
| 8.2.7 Australia | |
| 8.2.8 Australia | |
| 8.2.9 Indonesia | |
| 8.2.10 Thailand | |
| 8.2.11 Malaysia | |
| 8.2.12 Philippines | |
| 8.2.13 Vietnam | |
9 Europe |
|
9.1 Europe Immunotherapy Market Size YoY Growth 2016-2027 |
|
9.2 Europe Immunotherapy Market Facts & Figures by Country |
|
| 9.2.1 Europe Immunotherapy Sales by Country (2016-2021) | |
| 9.2.2 Europe Immunotherapy Revenue by Country (2016-2021) | |
| 9.2.3 Germany | |
| 9.2.4 France | |
| 9.2.5 U.K. | |
| 9.2.6 Italy | |
10 Latin America |
|
10.1 Latin America Immunotherapy Market Size YoY Growth 2016-2027 |
|
10.2 Latin America Immunotherapy Market Facts & Figures by Country |
|
| 10.2.1 Latin America Immunotherapy Sales by Country (2016-2021) | |
| 10.2.2 Latin America Immunotherapy Revenue by Country (2016-2021) | |
| 10.2.3 Mexico | |
| 10.2.4 Brazil | |
| 10.2.5 Argentina | |
11 Middle East and Africa |
|
11.1 Middle East and Africa Immunotherapy Market Size YoY Growth 2016-2027 |
|
11.2 Middle East and Africa Immunotherapy Market Facts & Figures by Country |
|
| 11.2.1 Middle East and Africa Immunotherapy Sales by Country (2016-2021) | |
| 11.2.2 Middle East and Africa Immunotherapy Revenue by Country (2016-2021) | |
| 11.2.3 Turkey | |
| 11.2.4 Saudi Arabia | |
| 11.2.5 UAE | |
12 Company Profiles |
|
12.1 Company 1 |
|
| 12.1.1 Company 1 Corporation Information | |
| 12.1.2 Company 1 Description and Business Overview | |
| 12.1.3 Company 1 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.1.4 Company 1 Immunotherapy Products Offered | |
| 12.1.5 Company 1 Recent Development | |
12.2 Company 2 |
|
| 12.2.1 Company 2 Corporation Information | |
| 12.2.2 Company 2 Description and Business Overview | |
| 2021-2027全球和中國免疫治療市場深入研究和趨勢預測報告 | |
| 12.2.3 Company 2 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.2.4 Company 2 Immunotherapy Products Offered | |
| 12.2.5 Company 2 Recent Development | |
12.3 Company 3 |
|
| 12.3.1 Company 3 Corporation Information | |
| 12.3.2 Company 3 Description and Business Overview | |
| 12.3.3 Company 3 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.3.4 Company 3 Immunotherapy Products Offered | |
| 12.3.5 Company 3 Recent Development | |
12.4 Company 4 |
|
| 12.4.1 Company 4 Corporation Information | |
| 12.4.2 Company 4 Description and Business Overview | |
| 12.4.3 Company 4 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.4.4 Company 4 Immunotherapy Products Offered | |
| 12.4.5 Company 4 Recent Development | |
12.5 Company 5 |
|
| 12.5.1 Company 5 Corporation Information | |
| 12.5.2 Company 5 Description and Business Overview | |
| 12.5.3 Company 5 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.5.4 Company 5 Immunotherapy Products Offered | |
| 12.5.5 Company 5 Recent Development | |
12.6 Company 6 |
|
| 12.6.1 Company 6 Corporation Information | |
| 12.6.2 Company 6 Description and Business Overview | |
| 12.6.3 Company 6 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.6.4 Company 6 Immunotherapy Products Offered | |
| 12.6.5 Company 6 Recent Development | |
12.7 Company 7 |
|
| 12.7.1 Company 7 Corporation Information | |
| 12.7.2 Company 7 Description and Business Overview | |
| 12.7.3 Company 7 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.7.4 Company 7 Immunotherapy Products Offered | |
| 12.7.5 Company 7 Recent Development | |
12.8 Company 8 |
|
| 12.8.1 Company 8 Corporation Information | |
| 12.8.2 Company 8 Description and Business Overview | |
| 12.8.3 Company 8 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.8.4 Company 8 Immunotherapy Products Offered | |
| 12.8.5 Company 8 Recent Development | |
12.9 Company 9 |
|
| 12.9.1 Company 9 Corporation Information | |
| 12.9.2 Company 9 Description and Business Overview | |
| 12.9.3 Company 9 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.9.4 Company 9 Immunotherapy Products Offered | |
| 12.9.5 Company 9 Recent Development | |
12.10 Company 10 |
|
| 12.10.1 Company 10 Corporation Information | |
| 12.10.2 Company 10 Description and Business Overview | |
| 12.10.3 Company 10 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.10.4 Company 10 Immunotherapy Products Offered | |
| 12.10.5 Company 10 Recent Development | |
12.11 Company 1 |
|
| 12.11.1 Company 1 Corporation Information | |
| 12.11.2 Company 1 Description and Business Overview | |
| 12.11.3 Company 1 Immunotherapy Sales, Revenue and Gross Margin (2016-2021) | |
| 12.11.4 Company 1 Immunotherapy Products Offered | |
| 12.11.5 Company 1 Recent Development | |
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis |
|
13.1 Immunotherapy Industry Trends |
|
13.2 Immunotherapy Market Drivers |
|
13.3 Immunotherapy Market Challenges |
|
13.4 Immunotherapy Market Restraints |
|
14 Value Chain and Sales Channels Analysis |
|
14.1 Value Chain Analysis |
|
14.2 Immunotherapy Customers |
|
14.3 Sales Channels Analysis |
|
| 14.3.1 Sales Channels | |
| 14.3.2 Distributors | |
15 Research Findings and Conclusion |
|
16 Appendix |
|
16.1 Research Methodology |
|
| 16.1.1 Methodology/Research Approach | |
| 16.1.2 Data Source | |
16.2 Author Details |
|
16.3 Disclaimer |
|
| List of Tables | |
| Table 1. Global Immunotherapy Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) | |
| Table 2. Major Manufacturers of Monoclonal Antibodies | |
| Table 3. Major Manufacturers of Therapeutic Vaccines | |
| Table 4. Major Manufacturers of Checkpoint Inhibitors | |
| Table 5. Major Manufacturers of Non-Specific Immunotherapy | |
| Table 6. Global Immunotherapy Market Size Growth Rate by Application (2021-2027) & (K Units) | |
| Table 7. Global Immunotherapy Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 | |
| Table 8. Global Immunotherapy Sales by Regions (2016-2021) & (K Units) | |
| Table 9. Global Immunotherapy Sales Market Share by Regions (2016-2021) | |
| Table 10. Global Immunotherapy Revenue by Regions (2016-2021) & (US$ Million) | |
| Table 11. Global Immunotherapy Sales Forecast by Region (2022-2027) & (K Units) | |
| Table 12. Global Immunotherapy Sales Market Share Forecast by Region (2022-2027) | |
| Table 13. Global Immunotherapy Revenue Forecast by Region (2022-2027) & (US$ Million) | |
| Table 14. Global Immunotherapy Revenue Market Share Forecast by Region (2022-2027) | |
| Table 15. Global Immunotherapy Sales by Manufacturers (2016-2021) (K Units) | |
| Table 16. Global Immunotherapy Sales Share by Manufacturers (2016-2021) | |
| Table 17. Ranking of Global Top Immunotherapy Manufacturers by Revenue (US$ Million) in 2020 | |
| Table 18. Immunotherapy Revenue by Manufacturers (2016-2021) (US$ Million) | |
| Table 19. Immunotherapy Revenue Share by Manufacturers (2016-2021) | |
| Table 20. Global Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) | |
| 2021-2027全球和中國免疫治療市場深入研究和趨勢預測報告 | |
| Table 21. Global Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapy as of 2020) | |
| Table 22. Key Manufacturers Immunotherapy Price (2016-2021) (US$/Unit) | |
| Table 23. Immunotherapy Manufacturers Manufacturing Base Distribution and Headquarters | |
| Table 24. Manufacturers Immunotherapy Product Type | |
| Table 25. Date of International Manufacturers Enter into Immunotherapy Market | |
| Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans | |
| Table 27. Global Immunotherapy Sales by Type (2016-2021) (K Units) | |
| Table 28. Global Immunotherapy Sales Share by Type (2016-2021) | |
| Table 29. Global Immunotherapy Revenue by Type (2016-2021) (US$ Million) | |
| Table 30. Global Immunotherapy Revenue Share by Type (2016-2021) | |
| Table 31. Immunotherapy Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) | |
| Table 32. Global Immunotherapy Sales Forecast by Type (2022-2027) & (K Units) | |
| Table 33. Global Immunotherapy Sales Market Share Forecast by Type (2022-2027) | |
| Table 34. Global Immunotherapy Revenue Forecast V (2022-2027) & (US$ Million) | |
| Table 35. Global Immunotherapy Revenue Market Share Forecast by Type (2022-2027) | |
| Table 36. Global Immunotherapy Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) | |
| Table 37. Global Immunotherapy Sales by Application (2016-2021) (K Units) | |
| Table 38. Global Immunotherapy Sales Share by Application (2016-2021) | |
| Table 39. Global Immunotherapy Revenue by Application (2016-2021) (US$ Million) | |
| Table 40. Global Immunotherapy Revenue Share by Application (2016-2021) | |
| Table 41. Immunotherapy Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) | |
| Table 42. Global Immunotherapy Sales Forecast by Application (2022-2027) & (K Units) | |
| Table 43. Global Immunotherapy Sales Market Share Forecast by Application (2022-2027) | |
| Table 44. Global Immunotherapy Revenue Forecast by Application (2022-2027) & (US$ Million) | |
| Table 45. Global Immunotherapy Revenue Market Share Forecast by Application (2022-2027) | |
| Table 46. Global Immunotherapy Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) | |
| Table 47. China Immunotherapy Sales (K Units) of Key Companies (2016-2021) | |
| Table 48. China Immunotherapy Sales Share by Company (2016-2021) | |
| Table 49. China Immunotherapy Revenue (US$ Million) by Company (2016-2021) | |
| Table 50. China Immunotherapy Revenue Share by Company (2016-2021) | |
| Table 51. China Immunotherapy Sales (K Units) by Type (2016-2021) | |
| Table 52. China Immunotherapy Sales Share by Type (2016-2021) | |
| Table 53. China Immunotherapy Revenue (US$ Million) Market Share by Type (2016-2021) | |
| Table 54. China Immunotherapy Price (US$/Unit) by Type (2016-2021) | |
| Table 55. China Immunotherapy Sales (K Units) by Type (2022-2027) | |
| Table 56. China Immunotherapy Sales Share by Type (2022-2027) | |
| Table 57. China Immunotherapy Revenue (US$ Million) Market Share by Type (2022-2027) | |
| Table 58. China Immunotherapy Revenue Share by Type (2022-2027) | |
| Table 59. China Immunotherapy Price (US$/Unit) by Type (2022-2027) | |
| Table 60. China Immunotherapy Sales (K Units) by Application (2016-2021) | |
| Table 61. China Immunotherapy Sales Share by Application (2016-2021) | |
| Table 62. China Immunotherapy Revenue (US$ Million) Market Share by Application (2016-2021) | |
| Table 63. China Immunotherapy Price (US$/Unit) by Application (2016-2021) | |
| Table 64. China Immunotherapy Sales (K Units) by Application (2022-2027) | |
| Table 65. China Immunotherapy Sales Share by Application (2022-2027) | |
| Table 66. China Immunotherapy Revenue (US$ Million) Market Share by Application (2022-2027) | |
| Table 67. China Immunotherapy Revenue Share by Application (2022-2027) | |
| Table 68. China Immunotherapy Price (US$/Unit) by Application (2022-2027) | |
| Table 69. North America Immunotherapy Sales by Country (2016-2021) & (K Units) | |
| Table 70. North America Immunotherapy Sales Market Share by Country (2016-2021) | |
| Table 71. North America Immunotherapy Revenue by Country (2016-2021) & (US$ Million) | |
| Table 72. North America Immunotherapy Revenue Market Share by Country (2016-2021) | |
| Table 73. Asia Pacific Immunotherapy Sales by Region (2016-2021) & (K Units) | |
| Table 74. Asia Pacific Immunotherapy Sales Market Share by Region (2016-2021) | |
| Table 75. Asia Pacific Immunotherapy Revenue by Region (2016-2021) & (US$ Million) | |
| Table 76. Asia Pacific Immunotherapy Revenue Market Share by Region (2016-2021) | |
| Table 77. Europe Immunotherapy Sales by Country (2016-2021) & (K Units) | |
| Table 78. Europe Immunotherapy Sales Market Share by Country (2016-2021) | |
| Table 79. Europe Immunotherapy Revenue by Country (2016-2021) & (US$ Million) | |
| Table 80. Europe Immunotherapy Revenue Market Share by Country (2016-2021) | |
| Table 81. Latin America Immunotherapy Sales by Country (2016-2021) & (K Units) | |
| Table 82. Latin America Immunotherapy Sales Market Share by Country (2016-2021) | |
| Table 83. Latin Americaa Immunotherapy Revenue by Country (2016-2021) & (US$ Million) | |
| Table 84. Latin America Immunotherapy Revenue Market Share by Country (2016-2021) | |
| Table 85. Middle East and Africa Immunotherapy Sales by Country (2016-2021) & (K Units) | |
| Table 86. Middle East and Africa Immunotherapy Sales Market Share by Country (2016-2021) | |
| Table 87. Middle East and Africa Immunotherapy Revenue by Country (2016-2021) & (US$ Million) | |
| Table 88. Middle East and Africa Immunotherapy Revenue Market Share by Country (2016-2021) | |
| Table 89. Company 1 Corporation Information | |
| Table 90. Company 1 Description and Business Overview | |
| Table 91. Company 1 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 92. Company 1 Immunotherapy Product | |
| Table 93. Company 1 Recent Development | |
| Table 94. Company 2 Corporation Information | |
| Table 95. Company 2 Description and Business Overview | |
| Table 96. Company 2 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 97. Company 2 Product | |
| Table 98. Company 2 Recent Development | |
| Table 99. Company 3 Corporation Information | |
| Table 100. Company 3 Description and Business Overview | |
| Table 101. Company 3 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 102. Company 3 Product | |
| Table 103. Company 3 Recent Development | |
| Table 104. Company 4 Corporation Information | |
| Table 105. Company 4 Description and Business Overview | |
| Table 106. Company 4 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 107. Company 4 Product | |
| Table 108. Company 4 Recent Development | |
| Table 109. Company 5 Corporation Information | |
| Table 110. Company 5 Description and Business Overview | |
| Table 111. Company 5 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 112. Company 5 Product | |
| Table 113. Company 5 Recent Development | |
| Table 114. Company 6 Corporation Information | |
| Table 115. Company 6 Description and Business Overview | |
| Table 116. Company 6 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| 2021-2027 quánqiú hé zhōngguó miǎnyì zhìliáo shìchǎng shēnrù yánjiū hé qūshì yùcè bàogào | |
| Table 117. Company 6 Product | |
| Table 118. Company 6 Recent Development | |
| Table 119. Company 7 Corporation Information | |
| Table 120. Company 7 Description and Business Overview | |
| Table 121. Company 7 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 122. Company 7 Product | |
| Table 123. Company 7 Recent Development | |
| Table 124. Company 8 Corporation Information | |
| Table 125. Company 8 Description and Business Overview | |
| Table 126. Company 8 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 127. Company 8 Product | |
| Table 128. Company 8 Recent Development | |
| Table 129. Company 9 Corporation Information | |
| Table 130. Company 9 Description and Business Overview | |
| Table 131. Company 9 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 132. Company 9 Product | |
| Table 133. Company 9 Recent Development | |
| Table 134. Company 10 Corporation Information | |
| Table 135. Company 10 Description and Business Overview | |
| Table 136. Company 10 Immunotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) | |
| Table 137. Company 10 Product | |
| Table 138. Company 10 Recent Development | |
| Table 139. Immunotherapy Market Trends | |
| Table 140. Immunotherapy Market Drivers | |
| Table 141. Immunotherapy Market Challenges | |
| Table 142. Immunotherapy Market Restraints | |
| Table 143. Immunotherapy Customers List | |
| Table 144. Immunotherapy Distributors List | |
| Table 145. Research Programs/Design for This Report | |
| Table 146. Key Data Information from Secondary Sources | |
| Table 147. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Immunotherapy Product Picture | |
| Figure 2. Global Immunotherapy Sales Market Share by Type in 2020 & 2027 | |
| Figure 3. Monoclonal Antibodies Product Picture | |
| Figure 4. Therapeutic Vaccines Product Picture | |
| Figure 5. Checkpoint Inhibitors Product Picture | |
| Figure 6. Non-Specific Immunotherapy Product Picture | |
| Figure 7. Global Immunotherapy Sales Market Share by Application in 2020 & 2027 | |
| Figure 8. Oncology | |
| Figure 9. Inflammation | |
| Figure 10. Central Nervous System | |
| Figure 11. Others | |
| Figure 12. Immunotherapy Report Years Considered | |
| Figure 13. Global Immunotherapy Market Size, (US$ Million), 2016 VS 2021 VS 2027 | |
| Figure 14. Global Immunotherapy Market Size 2016-2027 (US$ Million) | |
| Figure 15. Global Immunotherapy Sales 2016-2027 (K Units) | |
| Figure 16. Global Immunotherapy Market Size Market Share by Region: 2021 Versus 2027 | |
| Figure 17. Global Immunotherapy Sales Market Share by Region (2016-2021) | |
| Figure 18. Global Immunotherapy Sales Market Share by Region in 2020 | |
| Figure 19. Global Immunotherapy Revenue Market Share by Region (2016-2021) | |
| Figure 20. Global Immunotherapy Revenue Market Share by Region in 2020 | |
| Figure 21. Global Immunotherapy Sales Share by Manufacturer in 2020 | |
| Figure 22. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2020 | |
| Figure 23. Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 | |
| Figure 24. Global Immunotherapy Sales Market Share by Type (2016-2021) | |
| Figure 25. Global Immunotherapy Sales Market Share by Type in 2020 | |
| Figure 26. Global Immunotherapy Revenue Market Share by Type (2016-2021) | |
| Figure 27. Global Immunotherapy Revenue Market Share by Type in 2020 | |
| Figure 28. Global Immunotherapy Sales Market Share by Application (2016-2021) | |
| Figure 29. Global Immunotherapy Sales Market Share by Application in 2020 | |
| Figure 30. Global Immunotherapy Revenue Market Share by Application (2016-2021) | |
| Figure 31. Global Immunotherapy Revenue Market Share by Application in 2020 | |
| Figure 32. China Immunotherapy Sales Growth Rate 2016-2027 (K Units) | |
| Figure 33. China Immunotherapy Revenue Growth Rate 2016-2027 (US$ Million) | |
| Figure 34. China Immunotherapy Market Share in Global Market 2016-2027 | |
| Figure 35. China 5 and 10 Largest Immunotherapy Players Market Share by Revenue in Immunotherapy in 2020 | |
| Figure 36. China Immunotherapy Revenue Share by Type (2016-2021) | |
| Figure 37. China Immunotherapy Revenue Growth Rate by Type in 2016 & 2020 | |
| Figure 38. China Immunotherapy Revenue Share by Application (2016-2021) | |
| Figure 39. China Immunotherapy Revenue Growth Rate by Application in 2016 & 2020 | |
| Figure 40. North America Immunotherapy Sales Growth Rate 2016-2021 (K Units) | |
| Figure 41. North America Immunotherapy Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 42. North America Immunotherapy Sales Market Share by Country in 2020 | |
| Figure 43. North America Immunotherapy Revenue Market Share by Country in 2020 | |
| Figure 44. U.S. Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 45. U.S. Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 46. Canada Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 47. Canada Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 48. Europe Immunotherapy Sales Growth Rate 2016-2021 (K Units) | |
| Figure 49. Europe Immunotherapy Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 50. Europe Immunotherapy Sales Market Share by Country in 2020 | |
| Figure 51. Europe Immunotherapy Revenue Market Share by Country in 2020 | |
| Figure 52. Germany Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 53. Germany Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 54. France Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 55. France Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 56. U.K. Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 57. U.K. Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 58. Italy Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 59. Italy Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 60. Russia Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 61. Russia Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 62. Asia Pacific Immunotherapy Sales Growth Rate 2016-2021 (K Units) | |
| Figure 63. Asia Pacific Immunotherapy Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 64. Asia Pacific Immunotherapy Sales Market Share by Region in 2020 | |
| 2021-2027世界と中國免疫療法市場の詳細な研究と傾向予測レポート | |
| Figure 65. Asia Pacific Immunotherapy Revenue Market Share by Region in 2020 | |
| Figure 66. China Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 67. China Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 68. Japan Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 69. Japan Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 70. South Korea Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 71. South Korea Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 72. India Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 73. India Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 74. Australia Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 75. Australia Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 76. Taiwan, China Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 77. Taiwan, China Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 78. Indonesia Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 79. Indonesia Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 80. Thailand Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 81. Thailand Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 82. Malaysia Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 83. Malaysia Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 84. Philippines Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 85. Philippines Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 86. Vietnam Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 87. Vietnam Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 88. Latin America Immunotherapy Sales Growth Rate 2016-2021 (K Units) | |
| Figure 89. Latin America Immunotherapy Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 90. Latin America Immunotherapy Sales Market Share by Country in 2020 | |
| Figure 91. Latin America Immunotherapy Revenue Market Share by Country in 2020 | |
| Figure 92. Mexico Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 93. Mexico Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 94. Brazil Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 95. Brazil Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 96. Argentina Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 97. Argentina Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 98. Middle East and Africa Immunotherapy Sales Growth Rate 2016-2021 (K Units) | |
| Figure 99. Middle East and Africa Immunotherapy Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 100. Middle East and Africa Immunotherapy Sales Market Share by Country in 2020 | |
| Figure 101. Middle East and Africa Immunotherapy Revenue Market Share by Country in 2020 | |
| Figure 102. Turkey Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 103. Turkey Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 104. Saudi Arabia Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 105. Saudi Arabia Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 106. UAE Immunotherapy Sales Growth Rate (2016-2021) (K Units) | |
| Figure 107. UAE Immunotherapy Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 108. Immunotherapy Value Chain | |
| Figure 109. Channels of Distribution | |
| Figure 110. Distributors Profiles | |
| Figure 111. Bottom-up and Top-down Approaches for This Report | |
| Figure 112. Data Triangulation | |
| Figure 113. Key Executives Interviewed | |
略……
如需購買《2021-2027 Global and China Immunotherapy Market In-Depth Research and Trends Forecast Report》，編號：3152950
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號